The CW Journal is back - online!

Feast your eyes on brand new in-depth technology pieces and high-quality opinion articles - all available via our new CW Journal subsite.

CW name the three next companies to enter their 5G testbed

CW News published by CW (Cambridge Wireless)

The first companies into the CW 5G testbed - Camnexus, Extend Robotics and Ubisense – gained solid R&D results from the twelve week accelerator programme, ranging from new feature enablement to the discovery of significant cost savings.

Read about the first accelerator

Following this success, CW are pleased to announce the second cohort of companies to enter the 5G testbed.

HADO – developers of the first-ever physical esport in the world using Augmented Reality (AR) technology. Players strap on head-mounted displays and armband sensors to wield energy balls and shields on a real-world court as if by magic.

"We are investigating ways to make the experience of watching a HADO match as immersive as playing in one, something that can't be done without the low latency and high bandwidth of 5G."

Jim Sephton, HADO

Cambridge Sensoriis – this radar sensor design and consultancy company has over 25 years’ experience in creating systems that incorporate millimetre wave radar.

“Cambridge Sensoriis design high precision radar for long range, all weather outdoor sensing. These are deployed for different autonomy use cases including navigation for unmanned aerial systems (drones), or obstacle detection in front of cars.  Our radar provides rich data, for real time processing and control - using networked computing resources to interpret and combine radar with other sensors requires a low-latent high-bandwidth network.  We will use the 5G network to provide this network for our sensors with the high-reliability that the use cases require.”

Dr Steve Clark, CEO, Cambridge Sensoriis

Epitomical - is a technology company focused on developing Connected & Autonomous Systems for the Transport, Future of Mobility and Smart City markets with capabilities across Land, Air, Sea and Space.

“We’re excited to join the latest cohort and look forward to working with the CW team. 5G holds significant promise in terms of scaling wireless networks to include both man and machine in new ways. Our time with the testbed team will help Epitomical to build on our existing 5G R&D efforts and integrate commercial-grade 5G capabilities into Autorover, our Autonomous Rover platform. It will also allow us to demonstrate the multi-market and multi-service capabilities of Autorover coupled with the advantages that 5G offers, including sharing real-time & high bandwidth data, edge processing and integration of public and private 5G networks.”

Danish Alam, Director, Epitomical

About the Testbed

The CW 5G Private Network allows Cambridge’s world-renowned technology community to undertake cutting-edge digital research using 5G. All participating companies have access to an indoor 5G private network, the latest 5G-enabled devices, technology masterclasses and coaching in hardware and software development, project management and commercialisation support. It is housed in the TusPark building on the Cambridge Science Park and supported by Huawei.

If your company believes that 5G could benefit your products or services, contact Abhi Naha to discuss access to the testbed.

Subscribe to the CW newsletter

This site uses cookies.

We use cookies to help us to improve our site and they enable us to deliver the best possible service and customer experience. By clicking accept or continuing to use this site you are agreeing to our cookies policy. Learn more

Start typing and press enter or the magnifying glass to search

Sign up to our newsletter
Stay in touch with CW

Choosing to join an existing organisation means that you'll need to be approved before your registration is complete. You'll be notified by email when your request has been accepted.

Your password must be at least 8 characters long and contain at least 1 uppercase character, 1 lowercase character and at least 1 number.

I would like to subscribe to

Select at least one option*